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Abstract 
Objective: to measure patient preferences for their diabetic care in community setting 
Design: Discrete-choice survey  
Setting: community setting (primary physician and hospital sites) in Cyprus 
Participants: diabetic patients attending community sites 
Main Outcome Measure(s): patient preferences, to estimate which components of quality 
healthcare service people value, their relative importance, but also the potential shift to shared-
decision-making (SDM). 
Results: Older respondents with experience of the private sector already received SDM (managing 
their care and choosing their treatments; detailed and accurate information, continuity of care; 
compassion for their personal situation) from their primary care physician with waiting time shorter 
than one hour. They valued their ‘current’ option and they did not want to change it with other 
services. Younger people from the public sector valued a change in policy and wanted to move from 
their ‘current’ to alternative diabetic care services where the waiting times were shorter, they could 
not only manage their care but also choose their treatments (together with receiving information, 
continuity of care and compassionate care). Individuals agreed with receiving multidisciplinary care 
from a team of healthcare providers but they mostly preferred being supported by their primary 
care physician. The pooled sample valued their ‘current’ option but they also supported policy 
changes that would implement SDM service for everybody.   
Conclusions: Diabetic patients value SDM and are willing to support a shift of practice to receive it 
not only in the private but also in the public sector. The forthcoming National-Health-Insurance-
Service would aim to address such developments as anticipated both in the European Troika’s 
recommendations and the relevant laws 
Keywords: Community Health Care, Patient Preference, Patient satisfaction, Diabetes, Cyprus.  
Introduction  
Patient preferences for community care services has become an increasingly important aspect of 
healthcare policy in Europe; unfortunately much of the evidence collected in the literature is related 
to Northern European countries and limited data are available on the Mediterranean area.1  Cyprus, 
an eastern Mediterranean country that lacks of an universal coverage health system, is a quite 
unique case in Europe.2-3 A National Health Insurance System (NHIS),  as put forward and approved 
by law, which hasn’t yet been implemented,  provides for inclusion and coverage of all citizens, 
equity in contribution and in treatment provision, bolstering of patients’ rights,  introduction of cost-
containment policies towards the sustainability of the system, which will be applicable across the 
system, monitoring and medical audit control. Of particular interest is that none of these applies 
today in the private sector, while public sector travails to implement some of them.4-5 Pertinent to 
the patient’s empowerment, the competent authority for the introduction of the NHIS, the Health 
Insurance Organization, has appointed a member of the patient’s association in its board of 
directors, thus streamlining its operational framework with the need to engage patients and  also 
solidifying its support regarding  the  active role of patients  in the decision making process. 
Current health care sector features two fragmented systems, public and private sectors, which run in 
an uncoordinated and parallel way, with minimum cooperation, duplication of infrastructures and 
failure to achieve economies of scale, a significant aspect in Cyprus small health care market. We 
should underline that the two sectors are subject to different legislations, which further broadens 
the gap and perpetuates to inequity among patients. For instance, patient’s right officers are 
employed only in public hospitals. Moreover, private hospitals cannot operate pharmacies, while 
public do.   
The public sector provides free health care to a series of highly prevalent chronic conditions 
including diabetes1,6 affecting about 9.2 per cent of the Cypriot population, well above the average 
of 6.1 per cent in the European Union.7 An estimated 4 million euros (corresponding to the 5% of 
total pharmaceutical expenditure of public sector) is allocated for antidiabetic agents in the public 
health care sector. In the private sector, the corresponding amount is 3.4 million euros, nevertheless 
volume-wise public sector consumes significantly more quantities more since it procures medicines 
through tendering which plummets prices as low as 62% in the generics and 25% for branded 
products. This underlines another difference between the two sectors, diverging pricing approaches, 
which further compound the affordability issues of private sector patients, who pay all costs out-of-
pocket. The overall impact of endocrine-related diseases and conditions including diabetes 
translates in about 10% of the total annual health care expenditure (1.2 billion euro)for the country 8 
Overall 85% of total population who fulfil certain socioeconomic and employment status criteria are 
eligible for free public health care funded by the Ministry of Health, on a highly centralised context. 
The array of eligibility criteria is rather biased, which violates equity in access and favours some 
cohorts of the population. This leads to a grossly uneven access to public health care.9 The Public 
sector reimburses pharmaceuticals (including consumables and diagnostics) from a tender-based 
closed formulary, while the Private sector applies external price referencing. Failure of patients to 
tolerate or respond to the formulary products force them to the Private sector, whose affordability 
for patients has proven to be highly problematic.10 Although there is freedom of choice and the 
majority of the population are eligible for free public health care, out-of-pocket payment remains 
the primary source of health care funding indicating that people may disparage public health care, 
because of perceived issues of quality and long waiting times.11 Cost of private sector are borne out-
of-pocket unless patient is covered by an optional private health insurance. 
                                                          
1
 Patients in the public sector are subject to co-payment which come in the form of a fixed fee for physicians (3 
Euro for GP, 6 Euro for specialists) and 0.5 Euro for each medicine and laboratory test (both capped at 10 per 
prescription/ laboratory order form). 
  These attributes of Cyprus health system led to an oversupply of private sector, as illustrated by the 
second highest number per capita in Europe of high-cost technologies (e.g. computerized 
tomography scanners). This leads to high running cost that, in the context of the private sector, are 
shifted to private patients.12 The inertias of the system are further aggravated by minimum adoption 
of information technology, which leads to lack of coordination, and interruption of continuity of care 
both between public and private, but also between public primary and secondary care sectors, 
resulting in duplication of diagnostic activities. The lack of clinical guidelines has impeded the 
introduction of benchmarking and the consequent definition of performance targets, which 
unavoidably results into major variability of health outcomes among health centres.13-14 These 
features also limited monitoring and medical auditing.   
Although a number of the issues delineated above are experienced also in other Northern European 
countries featuring uncoordinated private and public systems (see for example the Republic of 
Ireland), Cyprus constitutes a quite unique case study to assess the provision of quality of healthcare 
in a challenging environment, that is still burdened by the ramifications of the fiscal crisis, that has 
further impeded the affordability of patients, which intertwined with access, especially in the private 
health care sector. This is further substantiated by the existence of only scarce data. So far, four 
patient satisfaction surveys were conducted.14-18 Unfortunately they were too broad and did not 
considered specific needs and opinions for diabetic patients looking for community care services and 
did not include any notion of strength of preference and relative importance between attributes of 
care.  
Current paper offers a unique perspective on decision-making criteria among Cyprus, using for the 
first time the discrete choice experiment (DCE) approach19-24 to capture Cypriot preferences for 
community care services across private and public sectors. DCE is an economic tool that can be used 
to study preferences for variety of healthcare services20, including diabetes care24. Its application to 
community care can demonstrate the value a particular healthcare service has when making 
decisions about quality care interventions to be implemented.25-27 This particular application 
investigated Cypriot patients’ preferences when choosing community care services for their diabetes 
care, and how they value shared decision making (SDM)26-29, as a process in which healthcare 
professionals and patients work together to select tests, treatments, management, or support 
packages, based on clinical evidence and patients’ informed preferences. In the field of SDM no 
studies have been performed in Cyprus, although some authors highlighted this lack and urged for 
its implementation.2   
Results from the DCE allowed to estimate the components of SDM that people value, their relative 
importance; and the potential willingness to shift to alternative healthcare services (compared with 
their ‘current’ option). Differences in preferences are presented across sectors. 
Methods 
The DCE questionnaire  
A description of the DCE questions is presented in here (see example in figure 1); however more 
details are provided in Appendix 1 on: the DCE choice set creation; questionnaire design and 
development; feasibility and piloting; theoretical validity; preparation for data collection and 
analysis; and ethical approval. First, respondents were asked to describe their ‘current’ option in 
terms of six characteristics:  
1. Information - whether they (rarely/never; sometimes; most of the times; always) receive 
detailed and accurate information about their care;  
2. Compassion -  whether they (rarely/never; sometimes; most of the times; always) receive 
care and compassion for their personal situation;  
3. Care management-  whether they can choose treatment options and manage care (I can 
choose my treatment options and manage my care; I can only choose my treatment options; 
I can only manage my care; None of them);  
4. Waiting time- their waiting time at the site (less than one hour; one hour; two hours; three 
hours or more);  
5. Continuity of care--  whether they receive community care from the same healthcare 
professional (primary care physician/nurse/specialist doctor);  
6. Who is providing care- the healthcare provider(s) delivering their care (primary care 
physician only; primary care physician and nurse; hospital physician/specialist only; hospital 
physician/specialist and nurse; primary care physician, hospital physician/specialist, and 
nurse).  
Following that, patients were then asked to complete a set of four DCE choices about their most 
preferred health care service. Each choice compared three separate alternatives (‘hypothetical 
Alternative A’, ‘hypothetical Alternative B’ and their ‘current’ option described by combinations of 
the same attributes and levels used above; see appendix 1). The set of choices was created 
according to best practice in the design of DCE (details are in Appendix 1). 
An additional set of questions addressed patients’ socio-demographic characteristics, and health 
status. 
 
Data collection, sample and sample size 
Seven separate community sites were involved in the study (four public and three private sites; see 
Appendix 2). They were chosen as a convenience sample of data collection sites distributed between 
urban and rural locations. A target recruitment of about 100 patients from public and private sites 
was estimated to be sufficient for comparing preferences across settings.30 The questionnaire was 
administered to diabetic patients aged 18 years or older whilst attending the community clinics. 
Subjects that were too ill to listen to the researcher were excluded from the study. A researcher was 
available during data collection in the community site to provide clarification and assistance in 
completing the questionnaire. After giving their signed consent, respondents were invited to 
complete a questionnaire either whilst waiting (with the option of completing it after the 
consultation) or later at home (to be returned to the site at their convenience). 
Analysis of data  
Only questionnaires with a completed DCE choice set and section on their ‘current’ option were 
considered for analysis.  Results from the raw statistics and regression model are presented for the 
pooled data (‘all Cyprus’) and for the two specific subgroups (‘Cyprus public’ vs. ‘Cyprus private’). 
Site characteristics, patient responses, aspects of their ‘current’ option, and demographic 
characteristics were analysed using raw statistics. Categorical data were described using frequencies 
and percentages, whilst continuous data were described with a mean and standard deviation. 
Differences between groups (‘Cyprus all’ vs. ‘Cyprus public’/’Cyprus private’; ‘Cyprus public’ vs. 
‘Cyprus private’) were tested using Chi squared and t independent group statistics for categorical 
and continuous variables respectively.  
The utility or satisfaction function, which specifies the relationship between the attributes and 
preferences, was derived from the DCE choice set and estimated using an appropriate regression 
model (see appendix 3).31 
Comparing policy changes across groups  
Two examples of change in healthcare practice were proposed (change in healthcare practice 1, 
from ‘current’ option to hypothetical ‘Alternative diabetic service 1’, and change in healthcare 
practice 2, from ‘current’ option to hypothetical ‘Alternative diabetic service 2’). Details on the 
actual characteristics attached to the alternative healthcare practices are presented in the results 
below. ‘Alternative diabetic services 1 and 2’ were chosen to reflect the preferred attribute levels’ 
combinations from the patient preferences.  Measure of patient satisfaction for the two proposed 
policy changes (compared with ‘current’ option) is provided by probability of uptake for changes; 
details are presented in appendix 4. 
Results 
Community sites, patient responses, and their socio-demographic characteristics  
Between July and September 2014, 192 eligible patients were identified across 7 community sites 
(see appendix 1). In the public and private subgroups, 92 and 72 eligible patients who received the 
survey completed it (90.2% and 80.0% respectively; see table 1).  Overall, 162 (84.3%) questionnaires 
were used for analysis, 90 (88.2%) in public and 72 (80%) in private settings. Individuals attending 
the private setting were older with more comorbidities but reported a better health status than 
those in the public setting (p<0.01; more in table 2). 
Patient ‘current’ option 
Current experience of diabetic care was positive across settings, and characterised by (appendix 5, 
‘Cyprus all’):  (i) receiving detailed and accurate information about their care, most of the 
times/Always, 96%; (ii) receiving care and compassion for their personal situation, most of the 
times/Always 95%; (iii) choosing treatment options and manage my care 43%; (iv) 1 hour or less 
waiting time at the site 77%; (v) receiving community care from the same healthcare provider 88%; 
(vi) receiving care from the primary care physician/primary care physician and nurse 64%. When 
looking at the setting-specific data, attributes’ levels combination for the ‘current’ option varied 
across groups (see appendix 5). ‘Cyprus private’ presented the best attribute combinations in terms 
of information (100% most of the times/always), compassion (100% most of the times/always), care 
management (100% managing their care, either alone or together with choosing treatment option), 
waiting time (100% one hour or less), and continuity of care (80%). The healthcare provider mostly 
approached in the private setting was the primary care physician (alone or with the primary care 
nurse, 96%). Difference across the three groups are presented in appendix 5. 
Patient preferences 
Results confirmed the theoretical validity of responses (see appendix 6). Respondents from ‘Cyprus 
private’ presented constant preference for their ‘current’ option and were not willing to trade for 
any alternative hypothetical service. DCE output are presented for the pooled sample ‘Cyprus all’ 
and subgroup ‘Cyprus public’ (see appendix 6). Overall respondents from ‘Cyprus all’ valued: 
receiving detailed and accurate information about their care (always/most of the times); receiving 
compassionate care (always/most of the times); choosing treatment options and managing their 
care; continuity of care; and receiving community from their primary care physician. The three most 
preferred service characteristics were: receiving community from their primary care physician 
(compared with hospital sites); receiving ‘always’ care and compassion for their personal situation; 
and receiving ‘always’ detailed and accurate information about their care. Waiting time was the least 
valued characteristic. More details are in appendix 6. 
Policy changes 
When comparing patient preferences across settings, the probability of uptake for alternative 
diabetes care services are easily interpretable measure of the relative importance placed on specific 
policy changes (listed in table 3), and figure 2 reports the results of this exercise. Both ‘Cyprus all’ 
and ‘Cyprus public’ wanted to change from their ‘current’ option to ‘alternative diabetic services’.  
For both groups the preferred policy change was represented by the shift to the ‘alternative diabetic 
services 2’ (probability of uptake was 90% for ‘Cyprus all’ compared with 96% for ‘Cyprus public’)  
offering: ‘always’ detailed and accurate information about their care’; ‘always’ care and compassion 
for their personal situation’; the opportunity to both ‘choose their treatment options, and manage 
their care’; 50% decrease in their ‘waiting time’; ‘care delivered by the physician, the hospital 
specialist and nurse’.   
Discussion  
This paper shows that Cypriot value SDM processes regarding their care for diabetes regardless of 
whether they seek private or public treatments. Private patients (who were already involved in SDM 
and supported by their primary care physician) presented constant preference for their ‘current’ 
option and were not willing to trade for alternative hypothetical services (status quo bias, where 
people are more likely to adopt a conservative response to health services innovations; see Tinelli et 
al26).  
Respondents from the public setting were younger people and had already some experience of what 
is regarded as SDM; however they could not ‘choose their treatment options and manage their care’, 
and their average ‘waiting time’ at the clinics was longer than one hour (both aspects highly valued 
by the respondents). Overall they valued a shift in policy and wanted to move from their current 
‘option’ to ‘alternative diabetic care services’ where the waiting times were shorter, they could not 
only manage their care but also choose their treatments, whist receiving ‘always detailed and 
accurate information about their care’, ‘care and compassion for their personal situation’, and 
‘continuity of care’. Individuals did value a team of multidisciplinary healthcare providers (change to 
service 1) but they preferred to receive support from their primary care physician (change to service 
2). 
The ‘all Cyprus’ sample valued their ‘current’ option but they were willing to change to ‘alternative 
diabetic care services’ where they could experience shorter waiting times, and be involved more in 
SDM.  Again, support from their primary care physician was preferred to coordinated care from a 
multidisciplinary team of healthcare professionals. It may be argued that, although over the past two 
decades32, most health systems have reoriented diabetes care from acute services to regular 
integrated management in the community setting, Cypriots are still very new to the concept of 
coordination between primary–secondary settings and they have still limited opportunities to 
experience it across private and public sectors.  Diabetes is particularly challenging to coordinate 
given the multiple healthcare providers and settings involved. International emphasis is now on 
integrated care which focuses on the organisation of management within settings and the 
coordination of care between settings.33-34 The overall findings from this Cypriot case study 
emphasize the need to implement anticipated more person centred healthcare system that would 
seek to unify public and private resources in a way that would allow patients to decide, on their own, 
the service provider who will fit their needs.12,35 The documented patient value of shorter waiting 
times, more personalised care, more information can be satisfied only within the context of a person 
centred healthcare system which will redistribute existing resources in more efficient allocation, 
allow people to choose their provider and support a quality performance scheme. The latter has 
proven to be very useful when promoting interaction between clinicians and their patients. 
Unfortunately we can anticipate that the public health care sector in Cyprus is highly unlikely to 
adopt to the findings of this study since currently there is recruitment freeze, an austerity measure, 
and many physicians leave public sector for the more profitable private sector, a trend which is 
aggravated by constant reduction in their remuneration –again an austerity measure.2 Consequently, 
public sector cannot cope effectively with patient’s demands and adjust to its new (expected) mode 
of action since demand has exceeded its functional capacity. The same applies for the private sector, 
which is totally financed by out-of-pocket payment, an attribute that leaves patients exposed to 
large health expenditure and violates the principles of health care provision, namely equity and 
solidarity, by not cross-subsidizing  both from rich to poor and from people at low risk of illness to 
people with higher risks. When comparing Cyprus to an alternative European setting such as England 
where person centred practices are already in place we found that Cypriots valued choosing 
alternative SDM services compared to their 'current' option, whereas the English preferred their 
status quo to other services.36 Several of these issues can be imputed to the lack of a universal 
coverage system. Indicatively, patient campaigns, medical audit and other efficiency enhancement 
activities such as electronic prescribing, performance management have been programmed once the 
NHIS is on, therefore is anticipated that this will address, at least to a certain degree some of our 
findings. This was also one of the European Troika’s recommendations as well, prior to the 
implementation of the bail-out agreement.  
Future work should allow to expand the limited sample size of this application (representing only 
0.2% of the 89,700 overall diabetes population in Cyprus) and allow to capture the levels of interest 
for the introduction of SDM not just within the diabetes but also within the overall patient 
community in Cyprus compared with other healthcare systems with similar issues. 
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 Table 1: Responses and versions of the questionnaire 
 Cyprus total Cyprus public Cyprus private 
 no. % no. % no. % 
Questionnaires 
distributed a 
192 100 102 100 90 100 
Questionnaires 
returned b 
164 85.4 92 90.2 72 80.0 
Questionnaires 
used for analysis c 
162 84.3 90 88.2 72 80.0 
Versions of the 
questionnaire 
      
1 53 32.7 28 31.1 25 34.7 
2 50 30.9 28 31.1 22 30.6 
3 59 36.4 34 37.8 25 34.7 
A: Questionnaires were distributed to the patients attending the community site by a member of the 
local research team; B: Questionnaires returned to the research team with attached consent form 
either at the community site or by post. C: Only questionnaires with completed DCE choice set and 
‘current’ option levels were considered for analysis.  
Note: differences between groups (Cyprus total vs. public/private; Cyprus public vs. private) were 
not significant at 0.05 level. 
Table 2: Patients’ socio-demographic characteristics 
 
 
Cyprus total Cyprus public 
P val  Cyprus 
private 
P val  P val  
  no. % no. % CT vs. CPu no. % CT vs. CPr CPu vs. CPr 
Age Mean (sd) 62.7 14 59.32 16.3 0.08 66.75 9.2 0.01 0.01 
Gender Male 62 48.1 37 48.1 0.99 25 48.1 0.99 0.99 
 
Female 67 51.9 40 51.9 27 51.9 
Health status 
Very poor 1 0.6 0 0.0 0.16 1 1.4 0.11 0.01 
Poor 1 0.6 1 1.2 0 0.0 
Average 22 14.2 17 19.8 5 7.2 
Good 87 56.1 55 64.0 32 46.4 
Very good 44 28.4 13 15.1 31 44.9 
Comorbidities 
Other 29 17.6 5 5.5 0.09 24 32.4 0.13 0.01 
Cancer 6 3.6 4 4.4 2 2.7 
Heart disease 21 12.7 14 15.4 7 9.5 
Asthma 7 4.2 3 3.3 4 5.4 
missing data/no co-morbidities 102 61.8 65 71.4 37 50.0 
Income 
In paid work 31 19.5 24 27.3 0.36 7 9.9 0.14 0.01 
Unemployed 7 4.4 4 4.5 3 4.2 
Retired from paid work 102 64.2 45 51.1 57 80.3 
Looking after family, home, or 
dependents 
11 6.9 8 9.1 3 4.2 
Others 8 5.1 7 8.0 1 1.4 
 
Table 3: Alternative diabetes care services to be compared 
 ‘Current’ option for Cyprus 
all (comparator) 
‘Current’ option for Cyprus 
public (comparator) 
Alternative diabetic service 1 Alternative diabetic service 2 
Detailed and accurate 
information about your 
care 
84% always; 12% most of the 
times; 4% sometimes 
74% always; 19% most of the 
times; 7% sometimes 
100% ‘always’ 100% ‘always’ 
Care and compassion for 
your personal situation 
85% always; 10% most of the 
times; 5% sometimes 
78% always; 13% most of the 
times; 9% sometimes 
100% ‘always’ 100% ‘always’ 
Choosing your treatment 
options, and manage 
your care 
43% ‘choosing their 
treatment options, and 
manage their care’; 47% 
‘managing their care 
only’;1%  I can only choose 
my treatment options; 9% 
none of them 
6% ‘choosing their treatment 
options, and manage their 
care’; 76% ‘managing their 
care only’; 2%  I can only 
choose my treatment 
options; 16% none of them 
100% ‘choosing their 
treatment options, and 
manage their care’ 
100% ‘choosing their 
treatment options, and 
manage their care’ 
Waiting time at the clinic 40 min 1 hour 50% decrease in their ‘waiting 
time’ 
50% decrease in their ‘waiting 
time’ 
Care from the same GP, 
nurse,  specialist doctor, 
or team of professionals  
88% Yes 93% Yes 100% Yes 100% Yes 
Who is providing your 
care 
33% Primary care physician 
only; 32% Primary care 
physician and nurse;  
3% Hospital physician/ 
specialist only;  
2% Hospital physician/ 
specialist and nurse;  
30% Primary care physician, 
hospital physician/specialist, 
and nurse 
40% Primary care physician  
and nurse;  
2% Hospital physician/ 
specialist only;  
3% Hospital physician/ 
specialist and nurse;  
55% Primary care physician, 
hospital physician/ 
specialist, and nurse 
100% ‘receiving care from 
primary care physician, 
hospital physician/specialist, 
and nurse’ 
100% ‘receiving care from 
primary care physician only’ 
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Supplementary material 
Appendix 1 
The discrete choice experiment (DCE) choice, and identification of attributes and their levels  
The DCE choice, the attributes and their levels were informed through appropriate review of the DCE 
literature, clinician interviews and field testing with patients and their representatives. The vignette 
presented the respondents with a hypothetical situation where they had to imagine that they need 
primary care for their diabetes. They were offered a choice of multiple diabetic services described in 
terms of: (i) Information, receiving detailed and accurate information about their care; (ii) 
Compassion, whether they could receive care and compassion for their personal situation; (iii) Care 
management, whether they could choose treatment options, and manage their care themselves; (iv) 
waiting time at the site; (v) Continuity of care, whether they could receive community care from the 
same healthcare professional; (vi) their care provider.  For more details see table A1.          
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Table A1: DCE attributes, their levels and coding 
ATTRIBUTES LEVELS [REGRESSION CODING] 
1) Information 
[receiving detailed and 
accurate information about 
their care] 
- Always [INFO3] 
- Most of the times [INFO2] 
- Sometime [INFO1] 
- Rarely/never a 
2) Compassion 
[receiving care and 
compassion for their 
personal situation] 
- Always [COMPASSION3] 
- Most of the times [COMPASSION2] 
- Sometime [COMPASSION1] 
- Rarely/never a 
3) Care management  
[choosing treatment 
options, and managing care] 
- I can choose my treatment options and manage my care [MANAGEMENT3] 
- I can only choose my treatment options [MANAGEMENT2] 
- I can only manage my care [MANAGEMENT1] 
- None of them a 
4) Waiting time 
[waiting time at the site] 
 
- Less than 1 hour a 
- 1 hour [TIME1] 
- 2 hours [TIME2] 
- 3 hours or more [TIME3] 
5) Continuity of care 
[receiving community care 
from the same primary care 
physician /nurse/specialist 
doctor] 
- Always [CONTINUITY3] 
- Most of the times [CONTINUITY2] 
- Sometime [CONTINUITY1] 
- Rarely/never a 
6) Who is providing care 
 
- Primary care physician only a 
- Primary care physician and nurse [PROVIDER1] 
- Hospital physician/specialist only [PROVIDER2] 
- Hospital physician/specialist and nurse [PROVIDER3] 
- Primary care physician, hospital physician/specialist, and nurse [PROVIDER4] 
Alternatives - Alternative community care service [ALTERNATIVE_SERVICE] 
- ‘Current’ situation a 
            a Reference level. 
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Choice set creation, questionnaire design, and development 
Two generic hypothetical alternatives and their ‘current practice’ were then compared within a 
series of 12 choice tasks generated using a D-optimal approach designed to elicit the maximum 
information from respondents (http://www.choice-metrics.com/). Since a 12 choice set could be 
excessively burdensome for respondents to complete in the limited time available at the community 
clinic, the 12 choice sets were divided into four separate versions of the questionnaire, each of them 
accommodating for the design D-optimal properties (http://www.choice-metrics.com/). Before 
completing the DCE exercise respondents were asked to describe the service received at their 
‘current practice’ to be kept as constant comparator for the entire choice set.  An example of choice 
is presented in figure 1. 
Robustness checks   
The theoretical validity of responses was explored by examining the sign and significance of 
parameter estimates. A priori, we expected respondents to prefer: Information [receiving detailed 
and accurate information about their care] (positive sign); Compassion [receiving care and 
compassion for their personal situation] (positive sign); Care management [choosing treatment 
options, and managing care] (positive sign); shorter waiting time [waiting time at the site] (negative 
sign); Continuity of care [receiving community care from the primary care physician/nurse/specialist 
doctor (positive sign); Who is providing care, multidisciplinary team (positive sign); and staying with 
their ‘current practice’ (negative sign).   
Testing the feasibility and piloting the questionnaire, and preparing for data collection and analysis  
Testing with patients was conducted in order to ensure that the most important attributes for the 
decision-making process of diabetic patients were included in the DCE and proper levels were used 
to each of the attributes as well as its length, its ability to be completed, and need for additional 
questions or possible rewording. No changes in the attributes and/or levels were deemed necessary 
based on the feedback received from discussion with 8 patients. A core group of researchers from 
the team had an active role in the adaptation and translation of the DCE questionnaire into Greek, 
supervised the implementation of the survey in preparation for data collection. 
Ethics approval 
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Ethical approval was granted by the London School of Economics Research Ethics Committee, the 
Health Research Authority in England (13/NW/0893), the Ministry of Health in Cyprus, the Cyprus 
Bioethics Committee and the Cyprus Office of Commission for the Protection of Personal Data. 
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Appendix 2:  Community care sites  
 All Cyprus Public sites 
n (%) 
Private sites 
n (%) 
Primary care practices 5 (71) 3 (75) 2 (67) 
Hospital clinics 2 (29) 1 (25) 1 (33) 
Rural location (vs urban) 2 (29) 2 (50) 0 
Multidisciplinary team at the 
clinics (primary care 
physician/hospital specialist and 
nurse)  
1 (14) 1 (25) 0 
Total  7 (100) 4 (100) 3 (100) 
 
. 
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Appendix 3:  Regression model: Multinomial conditional logit model 
The multinomial conditional logit model was used to analyse the response data, with the following 
utility function being estimated:   
Uji = Vji  + eji            Eq 1   
Where    
Vji = constant alternative service + β 1 INFO1 + β 2 INFO2 + β 3 INFO3 + β 4 COMPASSION1 + β 5 
COMPASSION2 + β 6 COMPASSION3 + β 7 MANAGMENT1 + β8 MANAGMENT2 + β 9 MANAGMENT3 + 
β 10TIME1 + β 11CONTINUITY1 + β 12PROVIDER1 + β 13PROVIDER2 + β 14PROVIDER3 + β 15PROVIDER4   
Eq 2  
  Uij = the utility of the jth choice to the ith individual, Vij is the systematic part of the utility function 
observable by the researcher and eji is the error term. Dummy variable were used to analyse 
categorical attributes, with reference levels identified in Appendix 1 (Table A1). The alternative 
practice constant is describing the general preference for alternative practice A or B over the 
‘current practice’, with the defined dummy variable omitted attributes’ level captured in these 
constants. β1- β15 are the coefficients to be estimated for the attributes. 
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Appendix 4: Policy analysis and probability choices for changes in diabetic care 
Results from the utility models can be used to estimate the probability of uptake for changes in 
policy to new diabetic services. This kind of information may be a useful contribution to policy 
analysis. We use results from the preferred model to estimate the impact of redesigning diabetes 
care in the community. In doing so, attribute levels are predefined and resultant utility scores 
converted to probabilities (see figure 2)13.  
Probabilities were calculated by using the following formula: Pc (alternative diabetic service 1) = exp 
(V1n)/Σj exp Vjn, where individual n will choose alternative diabetic service 1 within a choice set C of 
J (j = 1, ... , J) options.  
Vi = constant alternative service + β 1 INFO1 + β 2 INFO2 + β 3 INFO3 + β 4 COMPASSION1 + β 5 
COMPASSION2 + β 6 COMPASSION3 + β 7 MANAGMENT1 + β8 MANAGMENT2 + β 9 MANAGMENT3 + 
β 10TIME1 + β 11CONTINUITY1 + β 12PROVIDER1 + β 13PROVIDER2 + β 14PROVIDER3 + β 15PROVIDER4   
Eq 2  
β coefficients 1-15 and constant values are reported in appendix 6. 
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Appendix 5: ‘Current’ option 
  Cyprus all (CA) Cyprus 
public 
(CPu) 
 P value 
(CA vs. 
CPu) 
Cyprus 
private 
(CPr) 
 P value 
(CA vs. 
CPr) 
P value 
(CPr vs. 
CPu) 
  no. % no. %  no. %   
  162  90   72    
Do you receive 
detailed and 
accurate 
information about 
your care? 
Rarely/never 0 0.0 0 0.0 n/a 0 0.0 n/a n/a 
Sometimes 6 3.7 6 6.7 0 0.0 
Most of the time 20 12.3 17 18.9 3 4.2 
Always 136 84.0 67 74.4 69 95.8 
Do you receive care 
and compassion for 
your personal 
situation? 
Rarely/never 0 0 0 0 n/a 0 0 n/a n/a 
Sometimes 8 4.9 8 8.9 0 0 
Most of the time 16 9.9 12 13.3 4 5.6 
Always 138 85.2 70 77.8 68 94.4 
Can you choose your 
treatment options, 
and manage your 
care? 
None of them 14 8.6 14 15.6 0.01 0 0 0.01 0.01 
I can only manage my care 76 46.9 68 75.6 8 11.1 
I can only choose my 
treatment options 
2 1.2 2 2.2 0 0 
I can choose my treatment 
options and manage my 
care 
70 43.2 6 6.7 64 88.9 
What is your waiting 
time at the clinic? 
Less than 1 hour 87 53.7 16 17.8 0.01 71 98.6 0.01 0.01 
1 hour 39 24.1 38 42.2 1 1.4 
2 hours 29 17.9 29 32.2 0 0.0 
3 hours or more 7 4.3 7 7.8 0 0.0 
Do you receive care 
from the same 
GP/nurse/specialist 
doctor at the 
hospital? 
No 20 12.3 6 6.7 0.15 14 19.4 0.15 0.15 
Yes 142 87.7 84 93.3 58 80.6 
Who is providing 
your care? 
Primary care physician only 54 33.3 0 0.0 0.01 54 75.0 0.01 0.01 
Primary care physician  
and nurse 
51 31.5 36 40.0 15 20.8 
Hospital physician/ 
specialist only 
5 3.1 2 2.2 3 4.2 
Hospital physician/ 
specialist and nurse 
3 1.9 3 3.3 0 0.0 
Primary care physician, 
hospital physician/ 
specialist, and nurse 
49 30.2 49 54.5 0 0.0 
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Appendix 6: DCE results 
 Cyprus all Cyprus public  
 
 Coeff. SE P-val Coeff. SE P-val 
HEALTHCARE SERVICE CHARACTERISTICS 
Information [receiving detailed and accurate information about their care] 
(Compared to  Rarely/never)       
Sometimes 2.05 1.06 0.05 1.61 1.04 0.12 
Most of the times 2.01 0.81 <0.01 2.13 0.83 <0.01 
Always 2.20 0.65 <0.01 1.73 0.64 <0.01 
Compassion [receiving care and compassion for their personal situation] 
(Compared to  Rarely/never)       
Sometimes -0.38 0.92 0.67 -0.63 0.91 0.48 
Most of the times 2.11 .86 <0.01 1.41 0.92 0.12 
Always 2.69 .80 <0.01 2.35 0.84 <0.01 
Care management [choosing treatment options, and managing care] 
(compared to none of them)       
I can choose my treatment options 
and manage my care 
1.29 0.60 0.03 1.08 0.58 0.06 
I can only choose my treatment 
options 
-0.02 0.97 0.97 0.21 0.96 0.82 
I can only manage my care 1.37 0.62 0.02 0.93 0.64 0.14 
Waiting time [waiting time at the site] 
 -0.59 0.22 <0.01 -0.29 0.25 0.05 
Continuity of care [receiving community care from the same primary care physician/nurse/specialist 
doctor] 
(Compared to  Rarely/never)       
yes 1.69 0.55 <0.01 1.42 0.58 <0.01 
Who is providing care 
(Compared to GP only in England; 
Primary care physician only, in 
Cyprus) 
      
GP and nurse  in England (Primary 
care physician and nurse, in Cyprus) 
-0.24 0.73 0.73 0.55 0.85 0.51 
Hospital specialist only  in England 
(Hospital physician/specialist only, 
in Cyprus) 
-3.09 1.19 <0.01 -1.98 1.43 0.16 
Hospital specialist and nurse  in 
England  (Hospital 
physician/specialist and nurse, in 
Cyprus) 
-3.74 1.19 <0.01 -2.43 1.25 0.05 
GP, hospital specialist and nurse  in 
England  (Primary care physician, 
hospital physician/specialist, and 
nurse, in Cyprus) 
-2.41 0.75 <0.01 -1.21 0.90 0.17 
ALTERNATIVES 
(compared to current)       
Alternative community care service 0.61 0.36 0.09 0.64 0.36 0.07 
No of observations 637 351 
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No of individuals 162 90 
